Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents
- 1 July 1998
- journal article
- clinical trial
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 41 (1) , 15-23
- https://doi.org/10.1016/s0168-8227(98)00055-2
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Therapeutic problems in type II diabetic patients developing insulin requirementJournal of Diabetes and its Complications, 1996
- Insulin versus a combination of insulin and sulfonylurea in the treatment of NIDDM patients with secondary oral failureDiabetes Research and Clinical Practice, 1995
- Insulin therapy in Type II diabetesDiabetes Research and Clinical Practice, 1995
- What makes insulin injections painful?BMJ, 1991
- Characteristics of non-insulin-dependent diabetic patients with secondary failure to oral antidiabetic therapyThe American Journal of Medicine, 1989